BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27477687)

  • 21. Development of novel peptide inhibitor of Lipoxygenase based on biochemical and BIAcore evidences.
    Somvanshi RK; Singh AK; Saxena M; Mishra B; Dey S
    Biochim Biophys Acta; 2008 Nov; 1784(11):1812-7. PubMed ID: 18691678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study.
    El-Miligy MM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SA
    Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
    Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
    Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
    Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
    Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative structure activity relationship (QSAR) analysis of substituted 4-oxothiazolidines and 5-arylidines as lipoxygenase inhibitors.
    Choudhary AN; Kumar A; Juyal V
    Mini Rev Med Chem; 2010 Jul; 10(8):705-14. PubMed ID: 20412041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
    Lamie PF; Ali WAM; Bazgier V; Rárová L
    Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of anti-inflammatory and immunomodulatory effects of Premna integrifolia extracts and assay-guided isolation of a COX-2/5-LOX dual inhibitor.
    Azad R; Babu NK; Gupta AD; Reddanna P
    Fitoterapia; 2018 Nov; 131():189-199. PubMed ID: 30339925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
    Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
    Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent.
    Omar YM; Abdel-Moty SG; Abdu-Allah HHM
    Bioorg Chem; 2020 Apr; 97():103657. PubMed ID: 32086052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
    Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
    Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atropa acuminata Royle Ex Lindl. blunts production of pro-inflammatory mediators eicosanoids., leukotrienes, cytokines in vitro and in vivo models of acute inflammatory responses.
    Nisar A; Malik AH; Zargar MA
    J Ethnopharmacol; 2013 Jun; 147(3):584-94. PubMed ID: 23528361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurogenesis and neuroprotection in the adult brain. A putative role for 5-lipoxygenase?
    Manev H; Uz T; Manev R; Zhang Z
    Ann N Y Acad Sci; 2001 Jun; 939():45-51. PubMed ID: 11462800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and pharmacochemical study of new Cu(II) complexes with thiophen-2-yl saturated and alpha,beta-unsaturated substituted carboxylic acids.
    Panagoulis D; Pontiki E; Skeva E; Raptopoulou C; Girousi S; Hadjipavlou-Litina D; Dendrinou-Samara C
    J Inorg Biochem; 2007 Apr; 101(4):623-34. PubMed ID: 17276511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel lipoxygenase inhibitors as neuroprotective reagents.
    van Leyen K; Arai K; Jin G; Kenyon V; Gerstner B; Rosenberg PA; Holman TR; Lo EH
    J Neurosci Res; 2008 Mar; 86(4):904-9. PubMed ID: 17960827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
    Omar YM; Abdu-Allah HHM; Abdel-Moty SG
    Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a Prenyl Chalcone as a Competitive Lipoxygenase Inhibitor: Screening, Biochemical Evaluation and Molecular Modeling Studies.
    Zeraik ML; Pauli I; Dutra LA; Cruz RS; Valli M; Paracatu LC; de Faria CMQG; Ximenes VF; Regasini LO; Andricopulo AD; Bolzani VS
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives.
    Qandeel NA; El-Damasy AK; Sharawy MH; Bayomi SM; El-Gohary NS
    Bioorg Chem; 2020 Sep; 102():103890. PubMed ID: 32801081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach.
    P JJ; Manju SL; Ethiraj KR; Elias G
    Eur J Pharm Sci; 2018 Aug; 121():356-381. PubMed ID: 29883727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.